| mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
-0.0022 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0023 |
0.9 |
| mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.0024 |
0.9 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.0021 |
0.9 |
| mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
| mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
1 |
| mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
1 |
| mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
1 |